Procyanidin A1 (Synonyms: Proanthocyanidin A1; プロシアニジンA1)

Name: Procyanidin A1
Brand: MedChemExpress
SKU: HY-N2344
Rating: 5.0 (2 reviews)

製品番号: HY-N2344 純度: 99.34%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Procyanidin A1 (Proanthocyanidin A1) is a procyanidin dimer, which inhibits degranulation downstream of protein kinase C activation or Ca²⁺ influx from an internal store in RBL-213 cells. Procyanidin A1 has antiallergic effects.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Procyanidin A1 構造式

CAS 番号 : 103883-03-0

容量	価格（税別）	在庫状況	数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 254	在庫あり	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 254	在庫あり	Estimated Time of Arrival: December 31
Solid
1 mg	$100	在庫あり	Estimated Time of Arrival: December 31
5 mg	$200	在庫あり	Estimated Time of Arrival: December 31
10 mg	$320	在庫あり	Estimated Time of Arrival: December 31
25 mg	$640	在庫あり	Estimated Time of Arrival: December 31
50 mg	$1025	在庫あり	Estimated Time of Arrival: December 31
100 mg	$1640	在庫あり	Estimated Time of Arrival: December 31
200 mg		お問い合わせ
500 mg		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 2 publication(s) in Google Scholar

Other Forms of Procyanidin A1:

Cyanidin Chloride 在庫あり
Procyanidin B1 在庫あり
Procyanidin B2 在庫あり
Procyanidin C1 在庫あり
Procyanidin A2 在庫あり
Procyanidin B3 在庫あり
Procyanidin A1 (Standard) お問い合わせ

顧客検証

PKC アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

PKC PKCα PKCβ PKCγ PKCδ PKCε PKCη PKCζ PKCθ PKCμ PKC-ι ℩ PKCι

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
Jurkat	IC₅₀	> 70 3 Compound: 5	Cytotoxicity against human Jurkat cells after 24 to 72 hrs by MTT assay Cytotoxicity against human Jurkat cells after 24 to 72 hrs by MTT assay	[PMID: 23268742]
Jurkat	IC₅₀	>70 3 Compound: 5	Cytotoxicity against human Jurkat cells after 24 to 72 hrs by MTT assay Cytotoxicity against human Jurkat cells after 24 to 72 hrs by MTT assay	[PMID: 23268742]
Jurkat	IC₅₀	> 70 3 Compound: 5	Cytotoxicity against human Jurkat cells after 24 to 72 hrs by MTT assay Cytotoxicity against human Jurkat cells after 24 to 72 hrs by MTT assay	[PMID: 23268742]
MCF7	IC₅₀	> 70 3 Compound: 5	Cytotoxicity against human MCF7 cells after 24 to 72 hrs by MTT assay Cytotoxicity against human MCF7 cells after 24 to 72 hrs by MTT assay	[PMID: 23268742]
MCF7	IC₅₀	>70 3 Compound: 5	Cytotoxicity against human MCF7 cells after 24 to 72 hrs by MTT assay Cytotoxicity against human MCF7 cells after 24 to 72 hrs by MTT assay	[PMID: 23268742]
MCF7	IC₅₀	> 70 3 Compound: 5	Cytotoxicity against human MCF7 cells after 24 to 72 hrs by MTT assay Cytotoxicity against human MCF7 cells after 24 to 72 hrs by MTT assay	[PMID: 23268742]
MT4	IC₅₀	14 6 Compound: 8, proanthocyanidin A1	Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 10425115]
MT4	CC₅₀	144.3 6 Compound: 8, proanthocyanidin A1	Cytotoxicity against human MT4 cells by MTT assay Cytotoxicity against human MT4 cells by MTT assay	[PMID: 10425115]
MT4	CC₅₀	144.3 6 Compound: 8, proanthocyanidin A1	Cytotoxicity against human MT4 cells by MTT assay Cytotoxicity against human MT4 cells by MTT assay	[PMID: 10425115]
MT4	IC₅₀	14 6 Compound: 8, proanthocyanidin A1	Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 10425115]
MT4	CC₅₀	144.3 6 Compound: 8, proanthocyanidin A1	Cytotoxicity against human MT4 cells by MTT assay Cytotoxicity against human MT4 cells by MTT assay	[PMID: 10425115]
MT4	IC₅₀	14 6 Compound: 8, proanthocyanidin A1	Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay	[PMID: 10425115]
PBMC	IC₅₀	25 3 Compound: 3	Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IL2 production after 3 days by enzyme immuno assay Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IL2 production after 3 days by enzyme immuno assay	[PMID: 11975489]
PBMC	IC₅₀	25 3 Compound: 3	Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IL2 production after 3 days by enzyme immuno assay Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IL2 production after 3 days by enzyme immuno assay	[PMID: 11975489]
PBMC	IC₅₀	5.1 3 Compound: 3	Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IFN-gamma production after 3 days by enzyme immuno assay Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IFN-gamma production after 3 days by enzyme immuno assay	[PMID: 11975489]
PBMC	IC₅₀	30.6 3 Compound: 3	Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting	[PMID: 11975489]
PBMC	IC₅₀	25 3 Compound: 3	Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IL2 production after 3 days by enzyme immuno assay Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IL2 production after 3 days by enzyme immuno assay	[PMID: 11975489]
PBMC	IC₅₀	30.6 3 Compound: 3	Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting	[PMID: 11975489]
PBMC	IC₅₀	5.1 3 Compound: 3	Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IFN-gamma production after 3 days by enzyme immuno assay Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IFN-gamma production after 3 days by enzyme immuno assay	[PMID: 11975489]
PBMC	IC₅₀	5.1 3 Compound: 3	Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IFN-gamma production after 3 days by enzyme immuno assay Immunomodulatory activity in PHA-stimulated human PBMC assessed as inhibition of IFN-gamma production after 3 days by enzyme immuno assay	[PMID: 11975489]
PBMC	IC₅₀	30.6 3 Compound: 3	Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting Inhibition of PHA-stimulated human PBMC proliferation assessed as [3H]thymidine uptake after 3 days by scintillation counting	[PMID: 11975489]

体内実験

Procyanidin A1 suppress serum IgE and IgG1 levels in mice-immunized with ovalbumin^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

576.50

分子式

C₃₀H₂₄O₁₂

CAS 番号

103883-03-0

Appearance

Solid

Color

White to off-white

SMILES

O[C@@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC3=C4C(O[C@]5(C6=CC=C(O)C(O)=C6)OC7=CC(O)=CC(O)=C7[C@@]4([H])[C@H]5O)=CC(O)=C3C1

Structure Classification

Initial Source

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶剤 & 溶解度

体外:

DMSO : 100 mg/mL (173.46 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.7346 mL	8.6730 mL	17.3461 mL
5 mM	0.3469 mL	1.7346 mL	3.4692 mL
10 mM	0.1735 mL	0.8673 mL	1.7346 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.34 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.34 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (4.34 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

純度とドキュメンテーション

純度: 99.96%

Select Batch:

データシート (277 KB) SDS (393 KB)

COA (255 KB) HNMR (351 KB) CNMR (486 KB) RP-HPLC (245 KB) MS (228 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Tomochika K, et al. Effects of peanut-skin procyanidin A1 on degranulation of RBL-2H3 cells. Biosci Biotechnol Biochem. 2011;75(9):1644-8. [Content Brief]

[2]. Takano F, et al. Aqueous extract of peanut skin and its main constituent procyanidin A1 suppress serum IgE and IgG1 levels in mice-immunized with ovalbumin. Biol Pharm Bull. 2007 May;30(5):922-7. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.7346 mL	8.6730 mL	17.3461 mL	43.3651 mL
	5 mM	0.3469 mL	1.7346 mL	3.4692 mL	8.6730 mL
	10 mM	0.1735 mL	0.8673 mL	1.7346 mL	4.3365 mL
	15 mM	0.1156 mL	0.5782 mL	1.1564 mL	2.8910 mL
	20 mM	0.0867 mL	0.4337 mL	0.8673 mL	2.1683 mL
	25 mM	0.0694 mL	0.3469 mL	0.6938 mL	1.7346 mL
	30 mM	0.0578 mL	0.2891 mL	0.5782 mL	1.4455 mL
	40 mM	0.0434 mL	0.2168 mL	0.4337 mL	1.0841 mL
	50 mM	0.0347 mL	0.1735 mL	0.3469 mL	0.8673 mL
	60 mM	0.0289 mL	0.1446 mL	0.2891 mL	0.7228 mL
	80 mM	0.0217 mL	0.1084 mL	0.2168 mL	0.5421 mL
	100 mM	0.0173 mL	0.0867 mL	0.1735 mL	0.4337 mL

Procyanidin A1 Related Classifications

Inflammation/Immunology

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量		濃度		体積		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）	×	体積 _（開始）	=	濃度 _（終了）	×	体積 _（終了）
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Procyanidin A1103883-03-0Proanthocyanidin A1Procyanidin A 1Procyanidin A-1Proanthocyanidin A 1Proanthocyanidin A-1PKCProtein kinase CInhibitorinhibitorinhibit

最近チェックした製品:

製品名

カスタマ需要量 *

お名前 *

タイトル

メールアドレス *

電話番号 *

デパートメント

組纖名 *

市区町村

都道府県

国或いは地域 *

必ず会社名を記載ください。個人への返信は行いません。

備考

製品名

Lot #

お名前 *

メールアドレス *

電話番号 *

部門 *

組纖名 *

国或いは地域 *

備考

Procyanidin A1 (Synonyms: Proanthocyanidin A1; プロシアニジンA1)

カスタマーレビュー

Other Forms of Procyanidin A1:

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

PKC アイソフォーム固有の製品をすべて表示:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Procyanidin A1 Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

お名前
メール *

	Sorry, but the email address you supplied was invalid.

Procyanidin A1 (Synonyms: Proanthocyanidin A1; プロシアニジンA1)

カスタマーレビュー

Other Forms of Procyanidin A1:

Procyanidin A1 関連抗体

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

PKC アイソフォーム固有の製品をすべて表示:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Procyanidin A1 Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

カスタマーレビュー

Request for HNMR Report

Request for HNMR Report